Nippon Organon to Release Recombinant Follicle Stimulating Hormone Follistim.
The new products will be the first recombinant FSH agents to be marketed in Japan.
Compared to the conventional urine-derived FSH agent, Follistim has a purity of 99% and improves the pregnancy rate.
The new products are not to be covered by the National Health Insurance.
Source: JCN http://www.japancorp.net
Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
|Printer friendly Cite/link Email Feedback|
|Publication:||JCNN News Summaries|
|Date:||Aug 9, 2005|
|Previous Article:||Sankyo's Antihypertensive Agent, ARB Olmesartan to Be Available in Central and South America.|
|Next Article:||Asahi Breweries to Start Experimental Study of Biomass Ethanol Using High Biomass Sugarcane.|